PCM
PRAH

Penn Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Penn Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-13,637
Closed -$1.37M – 217
2020
Q2 		$1.37M Buy
13,637
+251
+2% +$23.4K 0.18% 165
2020
Q1 		$1.15M Sell
13,386
-861
-6% -$84K 0.19% 152
2019
Q4 		$1.58M Buy
+14,247
New +$1.47M 0.17% 180

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Penn Capital Management's PRAH Position: Q3 2020 in Review

Penn Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 13,637 shares — an estimated $1.37M sold.

Penn Capital Management first reported a position in PRAH in Q4 2019 and held it in 3 quarters. The position peaked at $1.58M in Q4 2019. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

  • Penn Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Penn Capital Management sold 13,637 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $1.37M.
  • Penn Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 3 quarters.
  • Penn Capital Management's PRA Health Sciences, Inc. position peaked at $1.58M in Q4 2019.
  • 281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on Penn Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.